Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and ...

When healthcare becomes simpler, reasonably priced, and genuinely accessible, India can finally bring advanced treatment to ...

Scientists at St. Jude analyzed medulloblastoma data to better understand treatment needs, lowering treatment intensity and ...

In this thrilling video, delve into the epic showdown between two of the most iconic extraterrestrial forces: Alien and ...

The next pandemic won’t just test our biology — it’ll test whether our AI and cybersecurity can survive the storm.

Cogent Biosciences, Inc. earns a Strong Buy rating due to positive phase 3 PEAK results for bezuclastinib + Sunitinib. Read ...

Candidates from different wings of the Democratic Party won key races on Election Day 2025 in the biggest test since ...

Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...

A handheld breath test flagged lung cancer risk in a 67-person study, using eight breath chemicals and a small on-device ...

WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

Geron reported Q3 2025 Rytelo revenues of $47.2M, down from $49M in Q2, with no underlying increase in demand reported. Click ...

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...